欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号HU/H/0589/002
药品名称Ceftazidim AptaPharma 2 g Powder for solution for injection/infusion
活性成分
    • ceftazidime 2.0 g
剂型Powder for solution for injection/infusion
上市许可持有人Apta Medica Internacional d.o.o. Likozarjeva ulica 6 Ljubljana 1000 Slovenia Telephone +386 51 300 343 Telefax +386 59 336 941 E-mail aljosa.rojec@apta-medica.com
参考成员国 - 产品名称Hungary (HU)
互认成员国 - 产品名称
    • Czechia (CZ)
      Ceftazidim AptaPharma
    • Romania (RO)
      Ceftazidimă AptaPharma, 2 g pulbere pentru soluție injectabilă/perfuzabilă
    • Slovenia (SI)
      Ceftazidim AptaPharma 2 g prašek za raztopino za injiciranje/infundiranje
    • Croatia (HR)
      Ceftazidim AptaPharma 1 g prašak za otopinu za injekciju/infuziju
    • Austria (AT)
      Ceftazidim AptaPharma 2 g Pulver zur Herstellung einer Injektions-/Infusionslösung
    • Poland (PL)
      Ceftazidime AptaPharma
    • Bulgaria (BG)
      Ceftazidim AptaPharma
许可日期2021/08/25
最近更新日期2024/02/23
药物ATC编码
    • J01DD02 ceftazidime
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase